Prescribing Habits of Doctors in Cardiovascular Disease in Bangladesh

Abstract

Cardiovascular diseases are a group of disorders of the heart and blood vessels and they include: coronary heart disease, cerebrovascular disease, peripheral arterial disease, rheumatic heart disease, congenital heart disease, deep vein thrombosis and pulmonary embolism etc. By 2030, almost 25 million people will die from cardiovascular diseases, mainly from heart disease and stroke. These are projected to remain the single leading cause of death. The objective of the present study was to find out the prescription habit of doctors in various cardiovascular diseases in Bangladesh. The survey of the study was conducted in National Institute of Cardiovascular Disease situated in Dhaka, the Capital City of Bangladesh. From the present study among the 715 prescription it was seen that among 715 patients 40% were female patient & 60% were male patient. It was seen that among 715 patients 2% were within 16-30 years, 10% were within 31-45 years, 49% were within 46-60 years , 28% were within 61-75 years & 11% were within 76-90 years. It was seen that among 715 patients 43% suffered from UA & HTN, 33% patient suffered from AMI & HTN, 16% patients suffered from UA & HTN & LVF, 8% patients suffered from LVF & IHD & 28% have HTN, 25% have unstable angina(UA), 20% have AMI, 18% have left ventricular failure, 9% have IHD. Among the 715 prescription, 33% patient used clopidogrel, 29% patient used glyceryl trinitrate, 14% patient used trimetazidine dihydrochloride, 9% patients used metoprolol, 7% patients used carvedilol, 5% patients used atorvastatin, 3% patient used digoxin. From the present study among the 715 prescription, controls of different pharmaceutical companies over total drug market for cardiovascular diseases were found out, And it was found out that 62% of the drug market for the management of cardiovascular diseases was controlled by Drug International Ltd as it is the company whose drugs are most prescribed. The Drug Include Nidocard (Glyceryl Ttrinitrite), Betaloc (Meteprolol Tartrate), Clopid (Clpidogrel Bisulphate). Aristopharma Pharmaceutical Share 17%. The Drug include Metacard and Agoxin. Beximco held their share at 7% & their drug is Atova. Sunpharma share 4% & their drug include Cardivas.